In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 28, 2021

    Endo, Arnold & Porter Accused Of Cover-Up In Opioid MDL

    Endo Pharmaceuticals and its Arnold & Porter lawyers are making "incredibly belated" discovery disclosures in multidistrict opioid litigation after a severe punishment for discovery violations in a separate opioid case, and an explanation under oath is needed, an Illinois federal judge heard Wednesday.

  2. July 27, 2021

    'Mountainous' Opioid Shipments Fed Crisis, Judge Told

    Lawyers for a small Appalachian county began closing arguments Tuesday in a West Virginia trial seen as an important test of liability for the opioid epidemic, arguing that the "Big Three" drug distributors' "mountainous" shipments fed multiple waves of addiction.

  3. July 23, 2021

    Opioid Wholesalers, W.Va. Gov'ts Set To Wrap Bellwether

    A two-day closing marathon in a bellwether opioid crisis trial in West Virginia federal court is set to start Tuesday after the city and county at the heart of the case battled in recent days to reinforce their position that distributors weren't invisible middlemen but causes of the problem.

  4. July 21, 2021

    Despite Fanfare, $26B Opioid Offer Far From Finish Line

    Wednesday's $26 billion offer from four drug companies to settle thousands of opioid crisis lawsuits might mark the beginning of the end for opioid litigation more broadly — but only if the offer is actually accepted, which appears far from certain.

  5. July 21, 2021

    AGs Unveil $26B Global Opioid Deal With J&J, Distributors

    The New York attorney general and six other state attorneys general on Wednesday formally announced a global opioid settlement worth $26 billion with Johnson & Johnson and the nation's three largest drug distributors.

  6. July 20, 2021

    J&J, Distributors Set To Unveil Opioid Deals Worth $26B

    Negotiators are expected to announce this week that they've hammered out the fine print on global opioid settlements worth $26 billion — including roughly $2.5 billion for attorney fees and costs — with Johnson & Johnson and the nation's largest drug distributors, a source close to the talks said Monday.

  7. July 09, 2021

    Native American Cases To Watch In 2nd Half Of 2021

    Native American law practitioners are anticipating developments in clashes over pipeline projects affecting tribal lands, white farmers' challenges in multiple federal courts to American Rescue Plan funding for minority farmers, and a fight over the environmental and religious rights fallout from a proposed Arizona copper mine.

  8. July 09, 2021

    Product Liability Cases To Watch: Midyear Review

    Long-awaited trials over the opioid crisis have started and the first federal bellwether case against major pharmacies is scheduled to kick off this fall, capturing product liability attorneys' attention for the second half of 2021.

  9. June 23, 2021

    Wis. Opioid Settlement Measure Clears State Legislature

    The Wisconsin Legislature has passed legislation giving its finance committee the power to greenlight a settlement in the sprawling multidistrict litigation against pharmaceutical companies over the opioid litigation, although the Badger State's attorney general on Wednesday called the legislation unconstitutional.

  10. June 23, 2021

    Judge Backtracks On Juror Vaccine Mandate In Opioid MDL

    An Ohio federal judge said on Wednesday he wouldn't automatically throw out potential jurors in the national multidistrict opioid litigation because they are unvaccinated against COVID-19, undoing an earlier order requiring juror vaccinations.